chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started to feel in the area of the administration redness, warm, pain, tenderness and iduration; Started to feel in the area of the administration redness, warm, pain, tenderness and iduration; Started to feel in the area of the administration redness, warm, pain, tenderness and iduration; Started to feel in the area of the administration redness, warm, pain, tenderness and iduration; This spontaneous case was received on 28-Oct-2022 from a physician assistant via Communications (reference number: SEQW22-05166) and concerned a 58-year-old female patient.  The patient's medical history included rheumatic fever as a child. The patient's concomitant medications were not reported.  On 24-Oct-2022, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine inact sag 4v; dose reported as '0.5 ml', route of administration: intramuscular (IM), anatomical location: not reported) for prevention of influenza disease. The batch number reported was AS4502A. The expiration date was 30-Jun-2023  On Wednesday, 26-Oct-2022, two days after Flucelvax administration, the patient started to feel in the area of administration redness, warm, pain, tenderness and induration.  At the time of initial reporting, the patient had not recovered from the events.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: A 58-year-old female patient experienced vaccination site erythema, vaccination site pain, vaccination site warmth, and vaccination site induration two days following vaccination with Flucelvax Quadrivalent. Causality for the reported events is assessed as probably related due to suggestive temporal relationship and biological plausibility. Per Brighton collaboration criteria, presented information correspond to level 3 diagnostic certainty for cellulitis at injection site.; Sender's Comments: A 58-year-old female patient experienced vaccination site erythema, vaccination site pain, vaccination site warmth, and vaccination site induration two days following vaccination with Flucelvax Quadrivalent. Causality for the reported events is assessed as probably related due to suggestive temporal relationship and biological plausibility. Per Brighton collaboration criteria, presented information correspond to level 3 diagnostic certainty for cellulitis at injection site.
p/vax pt small case chickenpox; T103; fine papular pink rash; abd; femoral;calf
Between 1 and 2 weeks after the second vaccine I noticed that my heart was racing most of the time, even when lying down.  I visited Dr during that time and my blood pressure, which is usually about 118/78, was instead  about 154/80.  I don't remember exactly, but much higher than usual.  It might have been 156/90, around there. My heart would beat fast enough to make me uncomfortable even when lying down.  The rapid heart beats lasted for about 2 months.  My blood pressure was back to normal by April.
Went in to BiPolar Mania and Rage.  One of the worst events I have had.  I take my meds, and have not had a Mania event since 2014.  There were no triggers for this event.   I have had Rage events more recently, last one 11 months ago.  But never both of these together.
Information  has been received from a physician concerning a patient who was vaccinated with a dose of Zostavax. it was reported that a day after vaccine was administered, the patient developed zoster of the eye. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Headache, NauseaVomiting, Skin sensitivity, Dizziness, and muscle soreness.  Narrative:
Patient is a 52-year-old male with past medical history of hypertension, PE on Xarelto, lobectomy d/t GSW in 1988 presenting for SOB and B/L foot swelling. Patient states he has had worsening shortness of breath over the past 1 week. He notes progressively worsening bilateral foot swelling as well over this timeframe. States the right foot is swelling worse than the left. He denies any associated chest pain. No fevers or chills. He does note associated dry cough. No nausea, vomiting or diarrhea. Patient is fully vaccinated for COVID 19, however states he was exposed to the virus about 1 week ago; just prior to symptom onset. He reports religious compliance with Xarelto; denies any missed doses. Nonsmoker. No hx cardiac disease. Pt has home O2 for use as needed since lobectomy, however does not normally require its use.
watery stool; injection site was super itchy; watery stool; injection site redness; nausea; tired; two hard knots at the injection site; 45 Mins after the shot she got tingling all over the body; tight chest; heart racing; tingling tongue and throat; swelling tongue and throat; difficulty swallowing; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat) and SWOLLEN TONGUE (swelling tongue and throat) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy and Sulfonamide allergy. Concomitant products included ETHAMBUTOL DIHYDROCHLORIDE (ATB) for Bronchitis.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat), SWOLLEN TONGUE (swelling tongue and throat), DYSPHAGIA (difficulty swallowing), INJECTION SITE INDURATION (two hard knots at the injection site) and FATIGUE (tired). On 11-Feb-2021, the patient experienced the first episode of DIARRHOEA (watery stool), INJECTION SITE ERYTHEMA (injection site redness) and NAUSEA (nausea). On 12-Feb-2021, the patient experienced the second episode of DIARRHOEA (watery stool) and INJECTION SITE PRURITUS (injection site was super itchy). At the time of the report, PARAESTHESIA (45 Mins after the shot she got tingling all over the body), CHEST DISCOMFORT (tight chest), PALPITATIONS (heart racing), PARAESTHESIA ORAL (tingling tongue and throat), SWOLLEN TONGUE (swelling tongue and throat), DYSPHAGIA (difficulty swallowing), the last episode of DIARRHOEA (watery stool), INJECTION SITE PRURITUS (injection site was super itchy), INJECTION SITE INDURATION (two hard knots at the injection site), INJECTION SITE ERYTHEMA (injection site redness), FATIGUE (tired) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not reported.
On 05/26/09 after receiving immunizations the child had rhythmic movements of arms and legs followed by lethargic periods where baby was unresponsive or drowsy for about 1/2 hour. He would suck on a pacifier. Baby felt cold to mother during the night. No spells on 5/27 but was hospitalized on 5/28 @ 19:50 until 5/29 @ 13:45 after having seizure like symptoms again that afternoon. No fever or illness noted. No episodes since then. Does have a grandmother on seizure medication. Neurologist contacted. Instructed if seizure >5 min. long have parents bring child to ER and EEG will probably be needed. Takes formula.  6/22/09 Hospital records / ICD-9 codes received DOS 5/28/09 to 5/29/09. Assessment: 'Episodic spells'. Patient presents with mother describing 'episodic spells' would 'ball up' and become unresponsive. Drowsy post for 1/2 hour. Neurologist recommends EEG if symptoms recur. ICD-9 codes: 780.39
GARDASIL lowered the immune system terribly and allowed her to contract diseases she otherwise wouldn't. She started with headaches, stomach aches, continuous nausea, low blood sugar, low blood pressure, general malaise, tiredness, sleep disturbances, lethargic, reflux, severe joint pain, brain fog, tingling, leg pain, depression, and anxiety. Previous to the vaccine she was a regular active child with no problems, very athletic. Now she can hardly run. This has been continuing since the vaccine to this current day. She has been diagnosed with Thyroid disease, Epstein-Barr Virus, PCOS, SMA Syndrome, Ankylosing Spondylitis, Herpes, etc.
Patient fully vaccinated with Pfizer (1/25/21, 2/22/21).   Patient hospitalized on 12/25/21 and found to be COVID positive.
Following administration of GARDASIL 9 vaccine, patient reported nausea and appeared pale. Given 6 oz of orange juice and candy and water. Vital signs monitored. Initially BP 72/39 and pulse 58. Color improved, reported feeling better. VS improved to 100/59, pulse 58 and then 94/56 pulse 76 before going home. Seen by provider before leaving office. Called parent later in day who reported patient felt much better, nausea resolved, eating well.
On 01/19/2002, she developed blisters in mouth, gums; face swelled, developed rashes/bruises on arms, legs, thighs and buttocks. mom described bruises as being "little tiny bruises, finger pirint and round, some in clusters and some single." Mom verbalized client's complaints or sore throat, cougn and had slight fever but fever never checked. Mom stated the client act really sick. The doctor was notified and they were told to give her Motrin and call the center. On 1/20-1/21, blisters were gone and on 01/22, only sore throat. The bruises were described as being black/brown looking.
Swelling, erythema, warm, painful x 24 hours. Tx with ice packs and Motrin
Injection site pain; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The reporter stated injection site pain from Shingrix vaccination and asked for remedies.
diarrhea; little energy, very tired; wants to lie down all the time; can't get a meal down; little energy, very tired; annoying headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ASTHENIA (little energy, very tired), HYPOKINESIA (wants to lie down all the time), EATING DISORDER (can't get a meal down) and FATIGUE (little energy, very tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer since 2014, Chronic obstructive pulmonary disease and Heart disease, unspecified.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), ASTHENIA (little energy, very tired), HYPOKINESIA (wants to lie down all the time), EATING DISORDER (can't get a meal down), FATIGUE (little energy, very tired) and HEADACHE (annoying headache). At the time of the report, DIARRHOEA (diarrhea), ASTHENIA (little energy, very tired), HYPOKINESIA (wants to lie down all the time), EATING DISORDER (can't get a meal down), FATIGUE (little energy, very tired) and HEADACHE (annoying headache) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.  No relevant concomitant medications were reported.   Treatment information was not provided.
tinnitus I noticed tinnitus for the first time in my life around/after my covid vacinne injection.  This was before I knew of any reported instances of tinnitus associated with the vaccine.  My neighbor had mentioned he developed it after his.  I closely watched mine to see if it went away.    I am reporting now in June of 2021 because it has not gone away and this data may be valuable.  I am not sure if it is vaccine related or not.  I teach science.   I think logically not irrationally.   All I know is I seemed to have have noticeable tinnitus for the first time in my life around the time I received the vaccine.   I will eventually follow up with an audiologist in the near future.  Submitting this report is my first action concerning this situation.
Pityriasis Rosea rash herald patch presented three days after initial injection and the rash kept spreading over my back, buttocks, shoulders, and legs. I continued to get my second vaccine and noticed a few more patches on my body, but there was not a dramatic increase in rash after the second dose.   Since the rash lasted about 4 weeks, I visited a dermatologist, today, May 7, and my doctor confirmed the rash was pityriasis rosea.
30 minutes post vax, the pt developed left periorbital and orbital edema with mild erythema of right lower eyelid.
On Monday November 28th I had several episodes of a loose stool and mild malaise including stomach pain, on Tuesday the 29th of November the stomach pain and malaise was severe. On Wednesday the thirteenth of November this continued with moderate abdominal pain and malaise. I saw my doctor and Appendicitis was ruled out a diet recommendation was given, this lasted for a week with no clarity as to cause.
Child received the 2nd varicella vaccine on 8/2/11. Site is swollen.
dizzy/dizziness; like vertigo for whole morning; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 85 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for COVID-19 Immunization. The following information was reported: DIZZINESS (non-serious), outcome "recovered", described as "dizzy/dizziness"; VERTIGO (non-serious), outcome "recovered", described as "like vertigo for whole morning".  Additional information: The patient reported some adverse event after the Pfizer Covid vaccine. She reported that she receive the second dose of Pfizer COVID Vaccine on Wednesday and four days later she experienced dizziness like vertigo the whole morning later in the day it got better and she does not have anything.  No follow up attempts are needed. No further information is expected.
Aches; Metallic taste in mouth; Ears red and hot; Ears red and hot; Nausea; Chills; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the left arm on 09Sep2021 at 19:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive concomitant medication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 18Aug2021 at 19:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient previously received codeine (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced allergy. On 10Sep2021 at 15:30, the patient experienced aches, metallic taste in mouth, ears red and hot, nausea and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches, metallic taste in mouth, ears red and hot, nausea and chills was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Felt lightheaded,  dizzy and nauseated.  Face became flush/red and felt warm.  However notes that she has felt nauseated since her miscarriage 5 days ago.
Information has been received from a health care professional at a physician's office concerning a 4 year old Hispanic female child who on 10/23/01 at 17:00 was vaccinated in the left thigh with the second dose of MMRII. Comcomitant vaccinations  included Infanrix in the left thigh, IPOL in the right thigh and Havrix in the right thigh. Illnesses at the time of vaccination included an upper respiratory infection and reactive cough. On 10/24/01 at 17:30,the child presented with an 18 x 17 cm area of erythema, warmth and induration at the left thigh and cellulitis of the left anterior thigh. It was also reported that the site was tender and swollen. The child was given Keflex and Motrin and was instructed to use coool compresses. It was reported that on 10/29/01, the child had recovered from all the events. No further information is expected. the health Care Professional also reported that a 13 month old female developed injection site erythema, swelling, induration, tenderness and warmth (see WAES01112249) and that a 12 month old female developedaskin lesion,and injectionsite swelling and tenderness (see WAES01112258)
fever 103.7 R; nonproductive cough for 2 days since recvd shots; already on PCN & Cardec DM; dx upper resp tract infect vax immun rxn;
Started having hives behind right ear, progressed to trunk area. By 12/7/10, had itchiness all over. Went to ED and got prednisone and Benadryl. On 12/8/10 had cramping and increased acid reflux. Was admitted to the hospital for questionable anaphylactic sensations. Vaccine injection site not red/symptomatic.
Chills, low-grade fever, joint pain, fatigue, reaction time delayed/much slower than usual
I had a temperature, chills, body aches, cough, sweating, and congestion. On started getting sick on 06/28/2022. I took a home COVID-19 test on 06/29/2022 and it was negative. I went to the pharmacy and took a test on 06/30/2022 and it was positive. I saw a doctor on 07/01/2022 and she prescribed me erythromycin and prednisone for 5 days. I was positive until yesterday 07/10/2022. I self-isolated for 5 days and wore a mask for 5 days. I tested negative on day 12 after getting symptoms. I think it was the BA5 variant.
SORENESS IN ARM; TIREDNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers No concomitant medications were reported.   On an unspecified date, the subject experienced soreness in arm, and tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the soreness in arm and tiredness was not reported. This report was non-serious.
CONTINUES HEADACHES , TIREDNESS, FOGGY THINKING, FORGET FULLNESS , LEFT ARM PAIN
Narrative:  71-year-old male with a history of CAD, diabetes, hypertension and obstructive sleep apnea presents to the hospital with 2 weeks of increasing shortness of breath, dyspnea on exertion and chest discomfort. He received the COVID-19 vaccine 3 weeks ago and thought maybe the symptoms were related to that. He has not had any infectious symptoms and continues to deny any fever, cough or sputum production. Chest pain is substernal, pressure like, exertional, but only lasts a few seconds and resolves. It is different from the pain he had in 2018 at the time of his stents. He has no history of CHF and is not on diuretics at home. He is a smoker and is not interested in quitting. He also has sleep apnea and reports compliance with CPAP. He denies any nausea, vomiting or diarrhea. He denies any abdominal pain. Symptoms:  Angina & chest discomfort radiating to left arm and shoulder, coming and going, progressive shortness of breath upon minimal exertion Treatment:
Redness at site of injection,  Itchy,  Slight swelling.  There was a hardness under the site first few days.  Rash started on the 11th of March mostly faded by today, March 19th.  Patched reached a size of 2" x 3"
Pt presented from rehab with shortness of breath and fever. Requiring oxygen.  Pt has cough also,tachycardia and rales.
Chills & shaking-lasted 24 hours Severe congestion-lasted 2 days Throat swelling-this happened the same time as the congestion started and made me feel like I could not breathe. It only lasted a few minutes.  Fever of 102.9-fever lasted less than 24 hours Severe headache and body aches-lasted 72 hours Nausea and vomiting-could not even keep anti-emetics down. Lasted 48 hours. I know many of these effects are considered a normal reaction to the vaccine. However, the  throat swelling and feeling like I could not breathe was concerning. It happened about 30 minutes after the chills/shaking started and right before I actually began to feel sick.
Covid arm - swelling , rash, red hot, measuring at least 8' x 6"
Debilitating pain and swelling at vaccination site with a ring around the shot.  Pain then transferred to other arm with body aches and low grade fever.  Pain at shot site duration was 10 days with no relieving factors.